Justinas Pašys

Co-Founder and CEO

8 past transactions

CyberUpgrade

Seed Round in 2024
CyberUpgrade provides cyber security as a service to traditional enterprises, software owners, and technology organizations. Assessments, staff awareness trainings, documentation preparation, advise on security tool integration, and much more are all included in the solution.

Ligence

Seed Round in 2024
Ligence is a Deep Tech startup based in Lithuania, specializing in healthcare solutions developed by a team of medical doctors proficient in artificial intelligence. The company focuses on automating heart ultrasound image analysis through its flagship product, Ligence Heart. This technology employs deep learning algorithms to accurately recognize various heart image views and perform essential measurements automatically. By streamlining the analysis process, Ligence Heart allows physicians to bypass manual measurements, enabling cardiologists and sonographers to enhance efficiency and significantly reduce analysis time, thereby allowing them to concentrate more on patient care and treatment.

Amlyze

Seed Round in 2024
AMLYZE is a RegTech company and Software-as-a-Service (SaaS) provider focused on combating financial crime through a comprehensive suite of solutions. The company offers modules for real-time and retrospective transaction monitoring, customer risk assessment, and various compliance investigations, including sanctions and politically exposed person (PEP) screening. Since its inception in 2019, AMLYZE has developed its core product, which launched in autumn 2022. The firm's strength lies in its team, composed of experts in anti-money laundering, financial fraud prevention, and market supervision, with backgrounds from prominent regulatory bodies and financial institutions. By leveraging this expertise, AMLYZE delivers innovative technology solutions that enhance the efficiency of AML/CFT compliance processes, helping clients mitigate reputational and financial risks while fulfilling regulatory obligations.

AISPECO

Seed Round in 2024
AISPECO is a Lithuanian company that specializes in geospatial monitoring systems for various types of vehicles, including helicopters, planes, unmanned aerial vehicles (UAVs), and terrestrial vehicles. The company develops aerial inspection systems specifically designed for conducting powerline surveys using helicopters and drones. Its platform is capable of capturing multiple types of imagery, such as optical, infrared, corona, and hyperspectral, which enhances the efficiency and effectiveness of infrastructure inspections. By focusing on advanced imaging technology, AISPECO enables clients to perform inspections with greater endurance and scalability in their operations.

Walk15

Seed Round in 2024
Walk15 is a sustainable walking platform focused on promoting health and active mobility among employees. The company offers a Sustainable Activity Platform that provides annual subscriptions to businesses, allowing them to engage their workforce in walking initiatives while tracking social impact data for environmental, social, and governance (ESG) reporting. Additionally, Walk15 has developed a mobile application that encourages users to participate in walking challenges, track their daily steps, and create private competitions with colleagues, friends, or family. The app also features trails for exploration, the ability to grow environmentally friendly virtual trees, and a Step Wallet where users can exchange their accumulated steps for discounts on various products and services. Through these offerings, Walk15 aims to enhance employee well-being and contribute to sustainability efforts in corporate environments.

CyberUpgrade

Pre Seed Round in 2024
CyberUpgrade provides cyber security as a service to traditional enterprises, software owners, and technology organizations. Assessments, staff awareness trainings, documentation preparation, advise on security tool integration, and much more are all included in the solution.

VUGENE

VUGENE specializes in bioinformatics and multi-omics data analysis for biomedical research and innovative therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.